Premium
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single‐nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4
Author(s) -
D'Avolio Antonio,
Ciancio Alessia,
Siccardi Marco,
Baietto Lorena,
Simiele Marco,
Cariti Giuseppe,
Calcagno Andrea,
Smedile Antonina,
Cusato Jessica,
Bonora Stefano,
Rizzetto Mario,
Di Perri Giovanni
Publication year - 2011
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.24636
Subject(s) - ribavirin , interleukin 28b , pegylated interferon , medicine , gastroenterology , single nucleotide polymorphism , hepatitis c virus , odds ratio , genotype , hepatitis c , immunology , pharmacology , virology , biology , virus , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom